{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:17:45Z","timestamp":1787876265403,"version":"build-2784847793"},"reference-count":71,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by increased platelet destruction and impaired platelet production, resulting in isolated thrombocytopenia. Despite advances in understanding disease pathophysiology, diagnosis remains challenging because no single clinical or laboratory test definitively establishes the diagnosis. Current international guidelines therefore continue to define ITP primarily as a diagnosis of exclusion based on clinical assessment, complete blood count, and peripheral blood smear evaluation.<\/jats:p>\n                  <jats:p>Recent developments in platelet immunology and laboratory diagnostics have expanded the range of adjunctive diagnostic tools. Glycoprotein-specific platelet autoantibody assays, including monoclonal antibody immobilization of platelet antigens (MAIPA)-based methods, provide high specificity for immune-mediated platelet destruction but remain limited by moderate sensitivity and restricted standardization. Biomarkers reflecting thrombopoiesis, particularly immature platelet fraction, thrombopoietin levels, support differentiation between hyperdestructive and hypoproductive thrombocytopenia, especially when integrated into multivariable diagnostic algorithms.<\/jats:p>\n                  <jats:p>Current diagnostic strategies differ across guidelines. Whereas ASH, ISTH-associated initiatives and Onkopedia recommendations emphasize restrained and clinically guided testing, the recent Japanese guideline incorporates thrombopoietin levels and immature platelet fraction into a more laboratory-oriented diagnostic framework. Overall, laboratory investigations should still be regarded as supportive rather than definitive. Future diagnostic strategies are expected to integrate clinical assessment with immunologic, thrombopoietic, and cellular biomarkers, enabling a more pathophysiology-based classification of thrombocytopenic disorders and improving diagnostic precision and individualized patient management.<\/jats:p>","DOI":"10.1055\/a-2926-8391","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:28:15Z","timestamp":1787873295000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnosing Immune Thrombocytopenia: An Update"],"prefix":"10.1055","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5068-3586","authenticated-orcid":false,"given":"Nina","family":"Cooper","sequence":"additional","affiliation":[{"name":"Justus-Liebig-Universitat Giessen, Hesse, Germany","place":["Giessen"],"department":["Institute for Clinical Immunology, Transfusion Medicine, and Haemostaseology"]},{"name":"University Hospital Giessen and Marburg Campus Giessen, HE, Germany","place":["Giessen"],"department":["Centre for Transfusion Medicine and Haemotherapy, incorporating the Department of Haemostasis and Thrombosis and the Haemophilia Centre"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich J.","family":"Sachs","sequence":"additional","affiliation":[{"name":"Justus-Liebig-Universitat Giessen, Hesse, Germany","place":["Giessen"],"department":["Institute for Clinical Immunology, Transfusion Medicine, and Haemostaseology"]},{"name":"University Hospital Giessen and Marburg Campus Giessen, HE, Germany","place":["Giessen"],"department":["Centre for Transfusion Medicine and Haemotherapy, incorporating the Department of Haemostasis and Thrombosis and the Haemophilia Centre"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"F Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"16","key":"ref2","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"C Neunert","year":"2011","journal-title":"Blood"},{"issue":"03","key":"ref3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ajh.21616","article-title":"The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports","volume":"85","author":"D R Terrell","year":"2010","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.eclinm.2019.07.015","article-title":"Chronic immune thrombocytopenia in Denmark, Sweden and Norway: the Nordic country patient registry for Romiplostim","volume":"14","author":"C F Christiansen","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"23","key":"ref5","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"C Neunert","year":"2019","journal-title":"Blood Adv"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000529662","article-title":"Expert report on immune thrombocytopenia: current diagnostics and treatment - recommendations from an expert group from Austria, Germany, and Switzerland","volume":"46","author":"A Matzdorff","year":"2023","journal-title":"Oncol Res Treat"},{"issue":"26","key":"ref7","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"D B Cines","year":"2009","journal-title":"Blood"},{"issue":"22","key":"ref8","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"D Provan","year":"2019","journal-title":"Blood Adv"},{"issue":"01","key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12185-023-03672-1","article-title":"Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition","volume":"119","author":"H Kashiwagi","year":"2024","journal-title":"Int J Hematol"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MOH.0000000000000612","article-title":"An update on the pathophysiology of immune thrombocytopenia","volume":"27","author":"J W Semple","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.lpm.2014.01.010","article-title":"Pathogenesis of immune thrombocytopenia","volume":"43","author":"D B Cines","year":"2014","journal-title":"Presse Med"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1538-7836.2003.00091.x","article-title":"Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP)","volume":"1","author":"R Mcmillan","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1046\/j.1365-2141.2003.04509.x","article-title":"The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb\/IIIa in patients with idiopathic thrombocytopenic purpura","volume":"122","author":"H Chan","year":"2003","journal-title":"Br J Haematol"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2018.211086","article-title":"Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia","volume":"104","author":"R Vollenberg","year":"2019","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1038\/ncomms8737","article-title":"Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"J Li","year":"2015","journal-title":"Nat Commun"},{"issue":"17","key":"ref16","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2016-03-708388","article-title":"Clinical relevance of antiplatelet antibodies and the hepatic clearance of platelets in patients with immune thrombocytopenia","volume":"128","author":"S Cantoni","year":"2016","journal-title":"Blood"},{"issue":"08","key":"ref17","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/bloodadvances.2023012155","article-title":"Human fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP","volume":"8","author":"L Gil Gonzalez","year":"2024","journal-title":"Blood Adv"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S0049-3848(16)30370-X","article-title":"Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance","volume":"141","author":"K M Hoffmeister","year":"2016","journal-title":"Thromb Res"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.thromres.2005.09.007","article-title":"A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF)","volume":"118","author":"Y Abe","year":"2006","journal-title":"Thromb Res"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pbc.22984","article-title":"Reduced expression of transforming growth factor-\u03b21 and correlated elevation of interleukin-17 and interferon-\u03b3 in pediatric patients with chronic primary immune thrombocytopenia (ITP)","volume":"57","author":"J-D Wang","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/asheducation.V2012.1.306.3798320","article-title":"Pathogenesis in immune thrombocytopenia: new insights","volume":"2012","author":"J Johnsen","year":"2012","journal-title":"Hematology"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP","volume":"103","author":"R McMillan","year":"2004","journal-title":"Blood"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance","volume":"80","author":"P J Ballem","year":"1987","journal-title":"J Clin Invest"},{"issue":"05","key":"ref24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3324\/haematol.2014.115634","article-title":"Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro","volume":"100","author":"M Iraqi","year":"2015","journal-title":"Haematologica"},{"issue":"07","key":"ref25","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jtha.2025.02.016","article-title":"Platelet autoantibodies have an impact on the platelet count in patients","volume":"23","author":"U J Sachs","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"25","key":"ref26","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1182\/bloodadvances.2017010942","article-title":"Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP registry","volume":"1","author":"D M Arnold","year":"2017","journal-title":"Blood Adv"},{"issue":"06","key":"ref27","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1182\/blood-2014-03-564328","article-title":"Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders","volume":"124","author":"P Noris","year":"2014","journal-title":"Blood"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/jth.12196","article-title":"Inherited thrombocytopenias frequently diagnosed in adults","volume":"11","author":"C L Balduini","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood.2022015936","article-title":"An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance database","volume":"140","author":"S Fuentes","year":"2022","journal-title":"Blood"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jth.12052","article-title":"A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia","volume":"11","author":"D M Arnold","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1538-7836.2009.03360.x","article-title":"Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management","volume":"7","author":"R H Aster","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"17","key":"ref32","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1182\/blood-2008-12-193664","article-title":"Molecular mimicry and immune thrombocytopenia","volume":"113","author":"R H Aster","year":"2009","journal-title":"Blood"},{"issue":"07","key":"ref33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood.2019003599","article-title":"Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment","volume":"135","author":"O Miltiadous","year":"2020","journal-title":"Blood"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V60.4.1050.1050","article-title":"A prospective study of the usefulness of the measurement of platelet- associated IgG for the diagnosis of idiopathic thrombocytopenic purpura","volume":"60","author":"J G Kelton","year":"1982","journal-title":"Blood"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2141.1989.tb06281.x","article-title":"A prospective comparison of four techniques for measuring platelet-associated IgG","volume":"71","author":"J G Kelton","year":"1989","journal-title":"Br J Haematol"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","article-title":"Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies","volume":"70","author":"V Kiefel","year":"1987","journal-title":"Blood"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bjh.15404","article-title":"Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art","volume":"182","author":"L Porcelijn","year":"2018","journal-title":"Br J Haematol"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1182\/blood-2003-09-3352","article-title":"Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura","volume":"103","author":"F Fabris","year":"2004","journal-title":"Blood"},{"issue":"04","key":"ref39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1423-0410.2007.00989.x","article-title":"A modified rapid monoclonal antibody-specific immobilization of platelet antigen assay for the detection of human platelet antigen (HPA) antibodies: a multicentre evaluation","volume":"93","author":"K Campbell","year":"2007","journal-title":"Vox Sang"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/bloodadvances.2019000868","article-title":"A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia","volume":"4","author":"H Al-Samkari","year":"2020","journal-title":"Blood Adv"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cca.2012.10.035","article-title":"Detection of autoantibodies against platelet glycoproteins in patients with immune thrombocytopenic purpura by flow cytometric immunobead array","volume":"415","author":"Y He","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12967-017-1317-2","article-title":"Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients","volume":"15","author":"J Zhai","year":"2017","journal-title":"J Transl Med"},{"issue":"07","key":"ref43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1537-2995.2010.02610.x","article-title":"The detection of platelet antibodies by simultaneous analysis of specific platelet antibodies and the monoclonal antibody-specific immobilization of platelet antigens: an interlaboratory comparison","volume":"50","author":"X D Nguyen","year":"2010","journal-title":"Transfusion"},{"issue":"05","key":"ref44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jth.14419","article-title":"The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test","volume":"17","author":"J R Vrbensky","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref45","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajh.25125","article-title":"Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two phase 3, randomized, placebo-controlled trials","volume":"93","author":"J Bussel","year":"2018","journal-title":"Am J Hematol"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1538-7836.2012.04664.x","article-title":"Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia","volume":"10","author":"D M Arnold","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0609.2011.01718.x","article-title":"Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)","volume":"88","author":"A Najaoui","year":"2012","journal-title":"Eur J Haematol"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0039-1678739","article-title":"Diagnosing immune thrombocytopenia","volume":"39","author":"U J Sachs","year":"2019","journal-title":"Hamostaseologie"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00277-013-1855-5","article-title":"Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding","volume":"93","author":"D Grimaldi","year":"2014","journal-title":"Ann Hematol"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/jth.12524","article-title":"Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study","volume":"12","author":"J Peng","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"11","key":"ref51","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s00277-021-04651-4","article-title":"Platelet features allow to differentiate immune thrombocytopenia from inherited thrombocytopenia","volume":"100","author":"G Bonnard","year":"2021","journal-title":"Ann Hematol"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.atherosclerosis.2009.02.008","article-title":"Mean platelet volume and the extent of coronary artery disease: results from a large prospective study","volume":"206","author":"De Luca","year":"2009","journal-title":"Atherosclerosis"},{"issue":"05","key":"ref53","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2141.2004.05357.x","article-title":"Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia","volume":"128","author":"K Kaito","year":"2005","journal-title":"Br J Haematol"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<19::AID-AJH4>3.0.CO;2-1","article-title":"Use of the platelet histogram maximum in evaluating thrombocytopenia","volume":"60","author":"A G Niethammer","year":"1999","journal-title":"Am J Hematol"},{"issue":"06","key":"ref55","doi-asserted-by":"crossref","first-page":"e094","DOI":"10.1097\/j.pbj.0000000000000094","article-title":"Diagnostic importance of mean platelet volume, platelet distribution width and platelet large cell ratio as screening tool in immune thrombocytopenia","volume":"5","author":"M I Khan","year":"2020","journal-title":"Porto Biomed J"},{"issue":"11","key":"ref56","doi-asserted-by":"crossref","first-page":"e0295011","DOI":"10.1371\/journal.pone.0295011","article-title":"The diagnostic accuracy of mean platelet volume in differentiating immune thrombocytopenic purpura from hypo-productive thrombocytopenia: a systematic review and meta-analysis","volume":"18","author":"M Walle","year":"2023","journal-title":"PLoS One"},{"issue":"06","key":"ref57","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1055\/s-0037-1615023","article-title":"The diagnostic value of Thrombopoietin level measurements in thrombocytopenia","volume":"79","author":"L Porcelijn","year":"1998","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref58","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1309\/RAW2-0LQW-8YTX-941V","article-title":"Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia","volume":"115","author":"Y Kurata","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"03","key":"ref59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood.V83.3.691.691","article-title":"Glycocalicin: a new assay--the normal plasma levels and its potential usefulness in selected diseases","volume":"83","author":"J H Beer","year":"1994","journal-title":"Blood"},{"issue":"05","key":"ref60","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/bjh.19987","article-title":"MicroRNA-199a-5p may be a diagnostic biomarker of primary ITP","volume":"206","author":"L Garabet","year":"2025","journal-title":"Br J Haematol"},{"issue":"9128","key":"ref61","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(98)05194-0","article-title":"A young woman with petechiae","volume":"352","author":"J Arnold","year":"1998","journal-title":"Lancet"},{"issue":"02","key":"ref62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0609.1998.tb01065.x","article-title":"Glycocalicin in the diagnosis and management of immune thrombocytopenia","volume":"61","author":"A Steffan","year":"1998","journal-title":"Eur J Haematol"},{"issue":"02","key":"ref63","first-page":"97","article-title":"Immunthrombozytopenie (ITP) und andere Thrombozytopenien in der Schwangerschaft","volume":"10","author":"A Matzdorff","year":"2020","journal-title":"Transfusionsmedizin - Immunh\u00e4matol, H\u00e4mother, Immungen, Zellther"},{"issue":"04","key":"ref64","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/vox.12894","article-title":"Anti-platelet antibody immunoassays in childhood immune thrombocytopenia: a systematic review","volume":"115","author":"D E Schmidt","year":"2020","journal-title":"Vox Sang"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jtha.2023.12.030","article-title":"Recombinantly expressed tagged SUrface protein (RETSUP) assay: a new diagnostic system for the detection of antibodies to platelets","volume":"22","author":"S Weber","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref66","first-page":"1725","article-title":"Differentiating pathogenic from bystander autoantibodies in immune thrombocytopenia using intact glycoproteindeficient megakaryocytes","volume":"111","author":"N Zhang","year":"2026","journal-title":"Haematologica"},{"issue":"05","key":"ref67","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.5937\/jomb0-52498","article-title":"Differently expressed miRNA in plasma samples of immune thrombocytopenic purpura patients and its clinical significance","volume":"44","author":"Y Yao","year":"2025","journal-title":"J Med Biochem"},{"issue":"22","key":"ref68","first-page":"6776","article-title":"Megakaryocyte- and platelet-derived microparticles as novel diagnostic and prognostic biomarkers for immune thrombocytopenia. Journal of","volume":"11","author":"W Wang","year":"2022","journal-title":"Clin Med"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1499014","DOI":"10.3389\/fimmu.2025.1499014","article-title":"The function of T cells in immune thrombocytopenia","volume":"16","author":"S Bu","year":"2025","journal-title":"Front Immunol"},{"issue":"06","key":"ref70","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/labmed\/lmaf020","article-title":"A study of soluble CD30 in patients with primary immune thrombocytopenia","volume":"56","author":"A MN Abdelrahman","year":"2025","journal-title":"Lab Med"},{"issue":"08","key":"ref71","doi-asserted-by":"publisher","first-page":"e70022","DOI":"10.1002\/rcm.70022","article-title":"Mass spectrometry-based proteomics to understand immune thrombocytopenic purpura: a review","volume":"40","author":"S K Raza","year":"2026","journal-title":"Rapid Commun Mass Spectrom"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2926-8391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:28:28Z","timestamp":1787873308000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2926-8391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":71,"URL":"https:\/\/doi.org\/10.1055\/a-2926-8391","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}